Dedicated to Improving Human Health

Learn About SNMMI

Support the FIND Act

The bi-partisan Facilitating Innovative Nuclear Diagnostics (FIND) Act will ensure patient access to these imaging procedures. 

Act Now!

SNMMI News Explore All News

Jun 26, 2024

Extended PSMA Therapy Safe and Effective for Prostate Cancer Patients

Reston, VA—Extended prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy (177Lu-PSMA) beyond six cycles is an effective and well-tolerated treatment for metastatic castration-resistant prostate cancer patients, according to

Read More

Jun 12, 2024

SNMMI 2024 Annual Meeting Spotlights Cutting-Edge Research, Spurring Innovation Across the Field

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted more than 8,000 physicians, technologists, pharmacists, laboratory professionals, scientists and others earlier this week at its 2024 Annual Meeting in Toronto, Ontario. Themed “Inn

Read More

Jun 11, 2024

New Chelating Agent Reduces Toxicity in PSMA Radiopharmaceutical Therapy

A newly developed chelator can significantly reduce off-target toxicity in prostate-specific membrane antigen (PSMA) radiopharmaceutical therapy, according to research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Mee

Read More

Patients

Looking for a healthcare facility that treats cancer using nuclear medicine therapies? The Society of Nuclear Medicine and Molecular Imaging designates medical centers that offer nuclear medicine therapy for patients with specific types of cancer. Check out SNMMI’s Therapy Centers of Excellence page to find sites near you.

Find Facilities

Researchers

With its innovative Clinical Trials Network, influential annual meeting and high-impact journals, SNMMI encourages and facilitates research and science for the nuclear medicine and molecular imaging field.

Learn More

Mars Shot

Supporting transformative nuclear medicine imaging and radiopharmaceutical therapy research that one day may be able to cure cancer.

Learn More

Become a Radiopharmaceutical Center of Excellence

SNMMI designated Radiopharmaceutical Therapy Centers of Excellence have affirmed that they have the training, personnel, equipment, and experience needed to manage patients requiring radiopharmaceutical therapy.

Learn More

Quick-Reference Protocol Manual for Nuclear Medicine Technologists (2d ed)

This book of protocols is created specifically for technologists; it harmonizes with the accepted guidelines for the procedures included but is written as a complementary reference source to serve the practical needs of technologists. It will assist technologists in providing the best possible patient care and image quality.

Learn More

Latest Journals

Journal of Nuclear Medicine

Founded in 1960, The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear medicine, molecular imaging and theranostics journal, accessed 15 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. JNM includes hot topics and state-of-the-art reports as well as clinical and basic science research in oncology, theranostics, neurology, cardiology, and radiation biology.

Subscribe

Journal of Nuclear Medicine Technology

JNMT is the only peer-reviewed publication dedicated to nuclear medicine technology. Published quarterly, each issue features continuing education articles written by leading educators in nuclear medicine technology as well as news and updates on practice, licensure, and credentialing for nuclear medicine technologists. Current credentialing, continuing education and licensure requirements are reported regularly.

Subscribe

SNMMI Membership

SNMMI is the preeminent provider of information and resources to the experts who are implementing and pioneering these lifesaving approaches to medicine.

Join SNMMI